Survival of HIV-infected patients with high-grade non-Hodgkin’s lymphomas: A retrospective study of experiences in Zimbabwe

BACKGROUND: Rituximab in combination with chemotherapy is now widely accepted as standard of care for AIDS-related lymphomas (ARLs) of B-cell origin. However, the clinical impact of rituximab in resource limited settings remains unknown. Different settings and patient heterogeneity may affect the ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Manyau, Maudy C. P., Mudzviti, Tinashe, Rusakaniko, Simbarashe, Mberi, Elson T., Maponga, Charles C., Morse, Gene D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498086/
https://www.ncbi.nlm.nih.gov/pubmed/32941540
http://dx.doi.org/10.1371/journal.pone.0239344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498086/
https://www.ncbi.nlm.nih.gov/pubmed/32941540
http://dx.doi.org/10.1371/journal.pone.0239344

Ejemplares similares